The downregulated BTN3A1 may be associated with the decrease of tumor‐infiltrating immune cells such as CD8+ T cells, dendritic cells, γδ T cells, and NK cells, leading to suppression of tumor inhibition effects and worse prognosis of patients. The gene discussed is CD8A; the disease is neoplasm.